The landscape of Patient-Reported Outcomes measurement is changing. Learn more about the facts, events, and trends from Mapi.
Get a top-level understanding of the Patient-Centered Outcomes environment for safe and wise decisions regarding where to invest and when to innovate.
Other topics covered include:
- regulators and payer expectations from the pharma industry (do they want more science, or less?);
- investing on measurement;
- review of the prior dynamic on Patient-Reported Outcomes claims;
- interpreting the recent changes affecting former SEALD group and the newly released pilot compendium;
- method/preference trends regarding disease areas (Oncology, CNS, Rare Diseases, etc.);
- and the pharma industry PRO resources organization.